13,004 Astera Labs, Inc. $ALAB Shares Bought by Russell Investments Group Ltd.

Russell Investments Group Ltd. lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 9.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 155,991 shares of the company’s stock after acquiring an additional 13,004 shares during the period. Russell Investments Group Ltd. owned 0.09% of Astera Labs worth $55,540,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Eurizon Capital SGR S.p.A. lifted its position in Astera Labs by 26.4% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 58,220 shares of the company’s stock valued at $20,725,000 after purchasing an additional 12,144 shares during the last quarter. R Squared Ltd bought a new position in Astera Labs in the 3rd quarter worth about $405,000. Maryland State Retirement & Pension System grew its position in Astera Labs by 9.4% in the 3rd quarter. Maryland State Retirement & Pension System now owns 9,126 shares of the company’s stock worth $3,249,000 after purchasing an additional 786 shares during the last quarter. Ritholtz Wealth Management grew its position in Astera Labs by 49.9% in the 3rd quarter. Ritholtz Wealth Management now owns 3,602 shares of the company’s stock worth $1,282,000 after purchasing an additional 1,199 shares during the last quarter. Finally, Jefferies Financial Group Inc. increased its stake in shares of Astera Labs by 470.8% in the third quarter. Jefferies Financial Group Inc. now owns 7,500 shares of the company’s stock valued at $2,670,000 after purchasing an additional 6,186 shares during the period. Institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In related news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the completion of the transaction, the director owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $211.41, for a total value of $1,901,421.54. Following the transaction, the director directly owned 1,987 shares in the company, valued at approximately $420,071.67. The trade was a 81.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 220,497 shares of company stock worth $62,043,303 in the last three months. Company insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $221.83 on Monday. The stock has a market cap of $38.77 billion, a price-to-earnings ratio of 88.38 and a beta of 3.86. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The stock’s 50 day moving average price is $294.27 and its 200 day moving average price is $257.09.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The firm had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. During the same period last year, the company posted $0.49 EPS. The firm’s quarterly revenue was up 153.6% on a year-over-year basis. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.99 EPS for the current year.

Astera Labs News Summary

Here’s some of the latest news about ALAB:

  • Positive Sentiment: An analyst raised the company’s FY2026 EPS forecast, a potentially supportive signal for earnings expectations. FY2026 EPS Forecast for Astera Labs Boosted by Analyst
  • Positive Sentiment: Strong demand for PCIe connectivity and AI infrastructure is supporting Astera Labs’ Aries and Scorpio products, providing potential growth opportunities. ALAB Benefits From Strong PCIe Demand
  • Negative Sentiment: Recent coverage describes a mixed trading picture: record Q3 growth is being offset by heavier selling pressure. It also flags competition from Marvell and Credo, which could challenge Astera Labs’ growth. Mixed Trading After Record Q3 Growth

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Needham & Company LLC dropped their price target on shares of Astera Labs from $425.00 to $300.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. Morgan Stanley boosted their price objective on Astera Labs from $382.00 to $389.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 4th. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Royal Bank Of Canada lowered their target price on Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 4th. Finally, TD Cowen lowered their target price on Astera Labs from $300.00 to $225.00 and set a “hold” rating on the stock in a research report on Wednesday, November 4th. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $320.85.

View Our Latest Research Report on Astera Labs

About Astera Labs

(Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.